Back to Search
Start Over
Clinical Utility of Patient-Derived Xenografts to Determine Biomarkers of Prognosis and Map Resistance Pathways in EGFR-Mutant Lung Adenocarcinoma.
- Source :
- Journal of Clinical Oncology; 8/1/2015, Vol. 33 Issue 22, p2472-2480, 11p
- Publication Year :
- 2015
Details
- Language :
- English
- ISSN :
- 0732183X
- Volume :
- 33
- Issue :
- 22
- Database :
- Supplemental Index
- Journal :
- Journal of Clinical Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 108463294
- Full Text :
- https://doi.org/10.1200/JCO.2014.60.1492